The Only Complete Online Marketing Firm
Sunday, May 31, 2015
ASCO: Triple Agent Tx Thwarts CLL Progress
(MedPage Today) -- Ibrutinib plus chemo and immunotherapy outplays standard treatment.
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment